Evidence map›Paper›PMID 36983044›Full record

ArticleInternational journal of molecular sciences2023

Germline Variants in MLH1 and ATM Genes in a Young Patient with MSI-H in a Precancerous Colonic Lesion.

Antonio Nolano, Giovanni Battista Rossi, Valentina D'Angelo, Raffaella Liccardo, Marina De Rosa, Paola Izzo, Francesca Duraturo

Open access · goldFull text readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Special Issue "Cancer Biomarker: Current Status and Future Perspectives".International journal of molecular sciences · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Antonio NolanoDepartment of Molecular Medicine and Medical Biotechnologies and CEINGE Advanced Biotechnologies Scarl, "Francesco Salvatore" Napoli, University of Naples Federico II, 80131 Naples, Italy.
Giovanni Battista RossiEndoscopy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semola, 80131 Naples, Italy.
Valentina D'AngeloEndoscopy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Via Mariano Semola, 80131 Naples, Italy.ORCID 0000-0002-4877-9979
Raffaella LiccardoDepartment of Molecular Medicine and Medical Biotechnologies and CEINGE Advanced Biotechnologies Scarl, "Francesco Salvatore" Napoli, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-2221-5825
Marina De RosaDepartment of Molecular Medicine and Medical Biotechnologies and CEINGE Advanced Biotechnologies Scarl, "Francesco Salvatore" Napoli, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-4752-5678
Paola IzzoDepartment of Molecular Medicine and Medical Biotechnologies and CEINGE Advanced Biotechnologies Scarl, "Francesco Salvatore" Napoli, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0003-1549-0615
Francesca DuraturoDepartment of Molecular Medicine and Medical Biotechnologies and CEINGE Advanced Biotechnologies Scarl, "Francesco Salvatore" Napoli, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-0787-6182
Ceinge Biotecnologie Avanzate (Italy) · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lynch syndrome (LS) is an autosomal dominant inherited disorder that primarily predisposes individuals to colorectal and endometrial cancer. It is associated with pathogenic variants in DNA mismatch repair (MMR) genes. In this study, we report the case of a 16-year-old boy who developed a precancerous colonic lesion and had a clinical suspicion of LS. The proband was found to have a somatic MSI-H status. Analysis of the coding sequences and flanking introns of the MLH1 and MSH2 genes by Sanger sequencing led to the identification of the variant of uncertain significance, namely, c.589-9_589-6delGTTT in the MLH1 gene. Further investigation revealed that this variant was likely pathogenetic. Subsequent next-generation sequencing panel analysis revealed the presence of two variants of uncertain significance in the ATM gene. We conclude that the phenotype of our index case is likely the result of a synergistic effect of these identified variants. Future studies will allow us to understand how risk alleles in different colorectal-cancer-prone genes interact with each other to increase an individual's risk of developing cancer.

Indexed as

Colorectal NeoplasmsEndometrial NeoplasmsPrecancerous ConditionsAtaxia Telangiectasia Mutated ProteinsDNA Mismatch RepairFemaleGerm CellsGerm-Line MutationHumansMicrosatellite InstabilityMutL Protein Homolog 1Ataxia Telangiectasia Mutated ProteinsATM protein, humanMLH1 protein, humanMutL Protein Homolog 1ATM geneLynch syndromeMMR genessynergist effect of risk allelesuncertain significance variants

Identifiers

PMID36983044
PMCPMC10051096
OpenAlexW4353071717

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read13
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.